RVMD — Revolution Medicines Share News
0.000.00%
Last trade - 00:00- $40.57bn
- $37.66bn
U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant
U.S. STOCKS ON THE MOVE -Revolution Medicines, FedEx, Cummins
Summit drops as concerns over older patients cloud cancer trial data (updated)
U.S. STOCKS ON THE MOVE -Revolution Medicines, FedEx, Xpeng
Revolution Medicines rises after pancreatic cancer drug doubles survival in study
Corrected: Revolution's pancreatic cancer drug doubles survival, boosts quality of life
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug (updated)
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
Brief: Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom
Promising Revolution Medicines pancreatic cancer drug has high rate of mostly manageable side effects
Revolution Medicines Q1 net loss widens on higher expenses
Brief: FDA Issues “Safe To Proceed” Letter To Initiate EAP For Revolution Medicines' Daraxonrasib
US FDA authorizes early access to Revolution's pancreatic cancer pill
Brief: F.D.A. Grants Early Access To Revolution Medicines Promising Drug Daraxonrasib For Pancreatic Cancer - NYT
Erasca shares sink after patient death in early-stage cancer drug trial (updated)
Erasca drops after patient death reported in early cancer trial
U.S. RESEARCH ROUNDUP-3M, Halliburton, Sherwin-Williams
Brief: Revolution Medicines Announces Closing Of Concurrent Upsized Public Offerings With Aggregate Gross Proceeds Of Approximately $2.2 Billion, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares
U.S. RESEARCH ROUNDUP- CME Group, M&T Bank, PNC Financial Services